Met amplification and tumor progression in Cdkn2a-deficient melanocytes

Pigment Cell and Melanoma Research

Volumn 22, Issue 4, 2009, Pages 454-460

  VanBrocklin, Matthew W ^a   Robinson, James P ^a   Whitwam, Todd ^b   Guilbeault, Adam R ^a   Koeman, Julie ^b   Swiatek, Pamela J ^b   Vande Woude, George F ^b   Khoury, Joseph D ^a   Holmen, Sheri L ^a  

^a NEVADA CANCER INSTITUTE   (United States)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Cdkn2a; Melanocytes; Met; Progression; Transformation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; TUBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CDKN2A GENE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE TARGETING; IN VIVO STUDY; MELANOCYTE; MELANOMA; MET GENE; METASTASIS; MOUSE; NONHUMAN; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; MELANOCYTES; MELANOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-MET; SKIN NEOPLASMS;

EID: 67749110396     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2009.00576.x     Document Type: Article

References (25)

1. Ahmed, I. (1997). Malignant melanoma: prognostic indicators. Mayo Clin. Proc. 72, 356 361.
2. Bastian, B.C., LeBoit, P.E., Hamm, H., Brocker, E.B. Pinkel, D. (1998). Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 58, 2170 2175.
3. Birchmeier, C., Birchmeier, W., Gherardi, E. Vande Woude, G.F. (2003). Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915 925.
4. Chin, L., Pomerantz, J. DePinho, R.A. (1998). The INK4a/ARF tumor suppressor: one gene - two products - two pathways. Trends Biochem. Sci. 23, 291 296.
5. Chin, L., Garraway, L.A. Fisher, D.E. (2006). Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev. 20, 2149 2182.
6. Davies, H., Bignell, G.R., Cox, C. et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949 954.
7. Ha, L., Ichikawa, T., Anver, M. et al. (2007). ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence. Proc. Natl Acad. Sci. USA 104, 10968 10973.
8. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. Thun, M.J. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58, 71 96.
9. Koprowski, H., Herlyn, M., Balaban, G., Parmiter, A., Ross, A. Nowell, P. (1985). Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somat. Cell Mol. Genet. 11, 297 302.
10. Lutterbach, B., Zeng, Q., Davis, L.J., Hatch, H., Hang, G., Kohl, N.E., Gibbs, J.B. Pan, B.S. (2007). Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival. Cancer Res. 67, 2081 2088.
11. Miller, C.T., Lin, L., Casper, A.M. et al. (2006). Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25, 409 418.
12. Moore, S.R., Persons, D.L., Sosman, J.A. et al. (2008). Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431). Clin. Cancer Res. 14, 2927 2935.
13. Natali, P.G., Nicotra, M.R., Di Renzo, M.F., Prat, M., Bigotti, A., Cavaliere, R. Comoglio, P.M. (1993). Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br. J. Cancer 68, 746 750.
14. Otsuka, T., Takayama, H., Sharp, R. et al. (1998). c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res. 58, 5157 5167.
15. Puri, N., Ahmed, S., Janamanchi, V., Tretiakova, M., Zumba, O., Krausz, T., Jagadeeswaran, R. Salgia, R. (2007). c-Met is a potentially new therapeutic target for treatment of human melanoma. Clin. Cancer Res. 13, 2246 2253.
16. Recio, J.A., Noonan, F.P., Takayama, H., Anver, M.R., Duray, P., Rush, W.L., Lindner, G., De Fabo, E.C., DePinho, R.A. Merlino, G. (2002). Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res. 62, 6724 6730.
17. Schaefer-Klein, J., Givol, I., Barsov, E.V., Whitcomb, J.M., VanBrocklin, M., Foster, D.N., Federspiel, M.J. Hughes, S.H. (1998). The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology 248, 305 311.
18. Schmidt, L., Duh, F.M., Chen, F. et al. (1997). Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16, 68 73.
19. Smolen, G.A., Muir, B., Mohapatra, G. et al. (2006a). Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesis. Cancer Res. 66, 3452 3455.
20. Smolen, G.A., Sordella, R., Muir, B. et al. (2006b). Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc. Natl Acad. Sci. USA 103, 2316 2321.
21. Vande Woude, G.F. (2008). Hepatocyte growth factor/scatter factor, Met and cancer references. http://www.vai.org/met/, last accessed date 9/16/2008.
22. Vindelov, L.L., Christensen, I.J. Nissen, N.I. (1983). A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3, 323 327.
23. Whitwam, T., Vanbrocklin, M.W., Russo, M.E., Haak, P.T., Bilgili, D., Resau, J.H., Koo, H.M. Holmen, S.L. (2007). Differential oncogenic potential of activated RAS isoforms in melanocytes. Oncogene 26, 4563 4570.
24. Wiltshire, R.N., Duray, P., Bittner, M.L., Visakorpi, T., Meltzer, P.S., Tuthill, R.J., Liotta, L.A. Trent, J.M. (1995). Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization. Cancer Res. 55, 3954 3957.
25. Zhao, X., Weir, B.A., LaFramboise, T. et al. (2005). Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res. 65, 5561 5570.